Panel discussion on...

Pet Supplements

Francesca Susca, DVM, Ph.D.1,
Cassandre Dujardin2
1. Global Category Manager Pet, Lallemand Animal Nutrition
2. Product Manager, Lallemand Health Solutions

Member of AgroFOOD Industry Hi Tech's Scientific Advisory Board

Pet Supplements Market Trends and Insights

The pet supplement category is entering a period of rapid evolution, driven by two powerful forces: pet humanization and the growing focus on healthy aging. As companion animals live longer and owners increasingly view them as family, the conversation around aging is shifting from treating problems after they appear to preventing them before they surface. This shift is fueling demand for supplements and functional ingredients that support mobility, maintain muscle mass, enhance cognition, and preserve overall vitality throughout a pet’s lifespan.


Yet this fastgrowing market also presents challenges. The category is more competitive than ever, and pet owners now want visible functional benefits, credible science, and clear differentiation. Brands capable of integrating functional ingredients as a true nutritional pillar, backed by robust evidence and transparent communication, will be the ones that stand out.


At the same time, the biggest opportunities lie in the revolution happening in microbial science. Advances in microbiome research are reshaping our understanding of how gut health influences

immunity, skin and coat condition, oral health, cognition, and emotional wellbeing. Probiotics continue to play a leading role, while postbiotics, valued for their stability, safety, and formulation flexibility, are opening the door to a new generation of targeted, condition specific solutions. Together, these microbial based ingredients allow manufacturers to elevate their value proposition and drive the next wave of innovation in pet supplements.


1B) Species specific research is essential when selecting and developing active ingredients for pets because dogs and cats have physiological, metabolic, immune, and microbiome characteristics that differ significantly from humans. Animal scientific models, such as mice can provide useful mechanistic insights that help guide the early stages of ingredient selection.


That said, differences in digestion, safety thresholds, microbiota composition, and dose–response relationships mean that efficacy, safety, and claims must always be validated in the target species. In short, animal scientific models can guide early understanding and help identify strains of interest, but species-specific research remains essential for responsible and credible pet product development.


1C)  The humanization of pets has undoubtedly encouraged consumers to pay closer attention to ingredient quality, scientific evidence, and overall pet wellbeing. However, it also brings a risk: pets do not metabolize ingredients the same way humans do, and benefits seen in human studies do not automatically translate to the same outcomes in animals.


In short, humanization raises awareness but without proper education, it can blur the boundaries between science based benefits and human driven assumptions. Helping consumers understand what is truly validated in pets and what remains marketing borrowed from the human wellness world is key to maintaining trust and ensuring responsible use of supplements.


1D) For functional ingredients in pet supplements, the key quality parameters are those that ensure reliable, repeatable performance. Ingredients must be standardized and consistent batch to batch, so the active components deliver the same effect every time. They also need to be bioavailable for dogs and cats, ensuring the actives can be effectively absorbed and utilized. Equally important is that these ingredients are easy to incorporate into different supplement formats (chews, powders, liquids) without causing formulation issues. Finally, proven stability throughout processing and shelf life is essential to ensure the promised benefits remain intact in the finished product.


1I) Owner reported outcomes are for sure less objective than veterinary assessments, but they remain essential because they reflect what truly happens in real life. They capture how pets behave and feel in their home environment and, importantly, how owners perceive the supplement’s benefits: a perception that strongly drives their willingness to purchase and continue using the product.


Today, in home studies are even more powerful: the ability to collect and analyze fecal samples or other biological samples allows researchers to combine a more commercial, real world approach with solid scientific validation. This integrated model (owner perception plus measurable biological changes) provides a realistic and highly relevant way to evaluate the true performance of pet supplements.

In this Panel Discussion, several prominent companies within the food and nutraceutical ingredient industry have been invited to discuss about drivers and barriers of healthy lifestyle, focusing on global and regional consumer trends, scientific achievements, emerging delivery formats, use of AI technologies and the implementation of the United Nations sustainability goals.

Panelists

Katrin Hedvall

Head of Food Sweden AFRY

Dr. Banu Sezer

Global Market Development Manager 
Anton Paar GmbH, Graz, Austria

Dr. Adam M. Adamek , PhD

CEO, Editor-in-Chief, Food Edge, Belgium

Elizabeth Koumpan

Distinguished Engineer and CTO 
for IBM iOps organization

Kirt Phipps

Principal Scientific Consultant –

Toxicology & Regulatory Affairs, Intertek

Dayna Lozon

Scientific Consultant 1 – Toxicology and Regulatory Affairs, Intertek

Karen E. Todd, RD

VP, Global Brand Marketing
Kyowa Hakko USA

René Floris

Chief Innovation Officer, CIO, 
NIZO Food Research

Veronika Pipan

Head of Scientific Support at PharmaLinea

Dr. Mariette Abrahams MBA

CEO & Founder of Qina